Mahshid Sadat Ansari

Mahshid Sadat Ansari

Auto-generated profile, based on publicly available information

Mahshid Sadat Ansari

Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2022 in Dermatologic Therapy
Verified
Journal Article
Closed access
SSSafoura Shakoei
Safoura Shakoei
YKYasamin Kalantari
Yasamin Kalantari
MNMaryam Nasimi
Maryam Nasimi
NTNasim Tootoonchi
Nasim Tootoonchi
MAMahshid Sadat Ansari
Mahshid Sadat Ansari
IEIfa Etesami
Ifa Etesami

7 April 2016 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
RARobabeh Abedini
Robabeh Abedini
KHKambiz Kamyab Hesari
Kambiz Kamyab Hesari
MDMaryam Daneshpazhooh
Maryam Daneshpazhooh
MAMahshid Sadat Ansari
Mahshid Sadat Ansari
HTHamid Reza Tohidinik
Hamid Reza Tohidinik
MAMahsa Ansari
Mahsa Ansari

9 March 2022 in Skin Appendage Disorders
Verified
Journal Article
Open access
PDF file
MNMaryam Nasimi
Maryam Nasimi
GGGholamreza Garmaroudi
Gholamreza Garmaroudi
MGMaryam Ghiasi
Maryam Ghiasi
VLVahideh Lajevardi
Vahideh Lajevardi
ZFZahra Fooladi
Zahra Fooladi
MAMahshid Sadat Ansari
Mahshid Sadat Ansari
Introduction: Lichen planopilaris (LPP) is a lymphocyte-mediated type of scarring alopecia and considered to have autoimmune etiology. Studies about systemic comorbid conditions are limited. Our goal is to identify the prevalence of medical comorbidities in patients with LPP. Methods: In a retrospective case-control study, the medical records of 208 LPP patients and 208 controls were reviewed for existing comorbidities such as thyroid diseases, cardiovascular disorders, hypertension, hyperlipidemia, and lupus erythematous. Results: Hyperlipidemia was found in 41.8% of all patients with LPP and in 17.3% of controls (p value <0.001, OR = 4.167). Chances of hypertension and cardiovascular disorders were lower in the LPP group in comparison to controls (p value = 0.009). Thyroid disorders were more prevalent in LPP patients, but the difference was not statistically significant (p value = 0.277). Conclusion: Our study further emphasizes that LPP patients should be screened for medical comorbidities, especially lipid profile abnormalities.

9 November 2023 in Skin Appendage Disorders
Verified
Journal Article
Closed access
PDF file
MNMaryam Nasimi
Maryam Nasimi
MAMahshid Sadat Ansari
Mahshid Sadat Ansari
Background: Lichen planopilaris (LPP) is an autoimmune disorder leading to lymphocytic cicatricial alopecia. Different agents such as hydroxychloroquine, methotrexate, cyclosporine, and mycophenolate mofetil have been tried to control hair loss with limited efficacy. JAK inhibitors are immune-modulating drugs which interfere with the JAK-STAT signaling pathway in lymphocytes and are used in treatment of inflammatory conditions such as rheumatoid arthritis and alopecia areata. Summary: Our aim was to determine effectiveness of JAK inhibitors in LPP and its clinical variant, frontal fibrosing alopecia. A literature search was conducted using PubMed, Google Scholar, and Cochrane databases. A total of 7 articles describing 35 patients were found. Although data on treatment are limited to retrospective studies and case reports, JAK inhibitors can be considered a new therapeutic option, especially in recalcitrant cases. Large prospective studies and randomized control trials are needed to provide further evidence supporting efficacy. Key Messages: Besides the fact that data on the treatment of LPP and FFA with JAK inhibitors are limited to retrospective studies and case reports, but JAK inhibitors can be considered as a new therapeutic option especially in recalcitrant cases.

8 April 2019 in Australasian Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
VLVahide Lajevardi
Vahide Lajevardi
HMHamidreza Mahmoudi
Hamidreza Mahmoudi
SMSamane Moghanlou
Samane Moghanlou
MAMahsa Ansari
Mahsa Ansari
ATAmir Teimourpour
Amir Teimourpour
MDMaryam Daneshpazhooh
Maryam Daneshpazhooh

24 January 2019 in International Journal of Dermatology
Verified
Journal Article
Closed access
ASAli Sadeghinia
Ali Sadeghinia
AGAlireza Ghanadan
Alireza Ghanadan
AEAmirhooshang Ehsani
Amirhooshang Ehsani
PNPedram Noormohammadpour
Pedram Noormohammadpour
MAMahshid S. Ansari
Mahshid S. Ansari